Treatment

OV Therapy

Arno Thaller provides investigational oncolytic virus (OV) treatment for eligible patients. OVs preferentially replicate within cancer cells and induce their death, while sparing healthy cells. They also infect tumor-associated endothelial cells, leading to breakdown of tumor vasculature and subsequent necrosis of uninfected tumor cells. In cancer cells, OVs rely on signaling pathways to establish infection and exploit defective anti-viral immune responsiveness to evade immune surveillance. The definition of “onco-lysis” is tumor destruction.

OV with cancer immunotherapy is a combined therapeutic approach.  The administered oncolytic virus (OV) attacks the cancer cells, leaving normal human cells untouched.  As a result this treatment has no significant side effects. Furthermore, OV combined with other therapies is a promising approach with potential to extend survival time and even cure, while quality of life is maintained. 

Arno Thaller, Physician

Arno Thaller

Arno Thaller is a physician with a clinic, Praxisklinik Arno Thaller, located in Markt Berolzheim, Bavaria, Germany.  He has long-standing clinical experience and expertise in oncology. He pioneered innovative therapeutic regiments for end-stage cancer patients and untreatable tumors. Based on the German regulation for innovative treatment for end-stage cancer patients, he combines the use of OV with new immunotherapeutic agents.

Professional Title

Approbation as a doctor: 1980 Sweden

Approval as a general practitioner by Bayerische Landesärztekammer in 1994

Recognition of additional qualification in naturopathy in 1994 by Bayerische Landesärztekammer

Supervisory Authority:

Kassenärztliche Vereinigung

KVB
Box 2536
90011 Nuremberg
Bayerische LandesärztekammerMühlbaurstr. 16
81677 Munich

http://www.blaek.de/

Link to the Rules of Professional Practice:

https://www.blaek.de/kammerrecht/berufsordnung-fuer-die-aerzte-bayerns

 

Praxisklinik Team

Arne Schroetz

Data Manager

Harald Schmoll

Physician Assistant

Christine Weißlein

 MFA, HP, Nurse

Ingrid Akva

Office Secretary

Consulting Oncologist: Prof. Dr. med. Karl R. Aigner

Medical Director of the Medias Klinikum GmbH & Co KG, a private clinic for oncological surgery Read more

About us

The ATGesundheit Institute website presents information about oncolytic virus (OV) cancer immunotherapy for glioblastoma multiforme (GBM), solid tumors and breast cancer. Our website is dedicated to exploring the therapeutic potential of OVs for incurable tumors and the therapeutic mechanisms of various OVs.

Contact US

ATGESUNDHEIT Institute
Email
Scroll to Top Skip to content